Next Article in Journal
CSF1R-Expressing Tumor-Associated Macrophages, Smoking and Survival in Lung Adenocarcinoma: Analyses Using Quantitative Phosphor-Integrated Dot Staining
Next Article in Special Issue
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Previous Article in Journal
The Tip of an Iceberg: Replication-Associated Functions of the Tumor Suppressor p53
Previous Article in Special Issue
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
 
 
Review

The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer

1
Medical Sciences, Indiana University School of Medicine, Bloomington, IN 47405, USA
2
Cell, Molecular and Cancer Biology Graduate Program, Indiana University, Bloomington, IN 47405, USA
3
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2018, 10(8), 251; https://doi.org/10.3390/cancers10080251
Received: 14 June 2018 / Revised: 20 July 2018 / Accepted: 24 July 2018 / Published: 30 July 2018
(This article belongs to the Special Issue The Tumor Microenvironment of High Grade Serous Ovarian Cancer)
Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC. View Full-Text
Keywords: inflammation; epithelial ovarian cancer; cytokines; reactive oxygen species; growth factors inflammation; epithelial ovarian cancer; cytokines; reactive oxygen species; growth factors
Show Figures

Figure 1

MDPI and ACS Style

Savant, S.S.; Sriramkumar, S.; O’Hagan, H.M. The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer. Cancers 2018, 10, 251. https://doi.org/10.3390/cancers10080251

AMA Style

Savant SS, Sriramkumar S, O’Hagan HM. The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer. Cancers. 2018; 10(8):251. https://doi.org/10.3390/cancers10080251

Chicago/Turabian Style

Savant, Sudha S., Shruthi Sriramkumar, and Heather M. O’Hagan. 2018. "The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer" Cancers 10, no. 8: 251. https://doi.org/10.3390/cancers10080251

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop